Companies: 10,795·Total market cap: $144.5T
TerrAscend Corp.

TerrAscend Corp.

TRSSFOTCHealthcare
$1.72
$-0.23(-11.79%)
Market Cap$601910591
P/E Ratio
52W High$3.09
52W Low$1.0
Overview

TerrAscend Corp. (TRSSF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TRSSF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.12trssf eps ttm · trssf earnings per shareEarnings history
PE Ratio (TTM)trssf pe ratio ttm · trssf price to earningsPE Ratio deep dive
Revenue (TTM)$255.1Mtrssf revenue ttm · trssf annual revenueFull revenue history
Dividend YieldNo Dividenddoes trssf pay dividends · trssf dividend yieldDividend history
Shares Outstanding301.1Mtrssf shares outstanding · trssf floatShares outstanding history
Next EarningsTBAtrssf earnings date · trssf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$260.6M▼ 15.04% YoY
202320242025
terrascend corp. revenue · trssf revenue 2025
FY 2025Net Income-$81.3M▼ 1.37% YoY
202320242025
terrascend corp. net income · trssf profit 2025
FY 2025EPS$-0.29▼ 3.57% YoY
202320242025
trssf eps · terrascend corp. earnings per share 2025
TTM:Revenue: $255.1MNet Income: -$77.0MEPS: $-0.12View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold3 analystsis trssf a buy · trssf analyst rating
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$2.85Low
$1.72Current
$2.93Avg Target70.35% upside
$3.00High
trssf price target · trssf 12 month forecast

Total: 3 · Buy rate: 33.3%

The TRSSF analyst consensus is Hold, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $2.93, representing +70.35% upside from the current price of $1.72.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M-4.97%
3M+0.00%
YTD+54.84%
1Y-26.50%
5Y-46.25%

About TerrAscend Corp.

CEOZiad Ghanem
IPO DateNov 17, 2017
Employees972
CountryCA

TerrAscend Corp. operates as a vertically integrated cannabis company, engaged in the cultivation, processing, and sale of both medical and adult-use cannabis across Canada and the United States. Beyo…

what is terrascend corp. · trssf stock overview · terrascend corp. company profile · who is terrascend corp. ceo · trssf OTC · terrascend corp. headquarters · terrascend corp. business segments

About Stock Overview & Key Data

TerrAscend Corp. (TRSSF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 17, 2017. As of the latest trading session, TRSSF stock price is $1.72, with a market capitalization of $601.9M. The stock has returned -26.50% over the past 12 months and +54.84% year-to-date.

According to 3 Wall Street analysts, the consensus rating for TerrAscend Corp. stock is Hold, with an average 12-month price target of $2.93. In fiscal year 2025, TerrAscend Corp. reported revenue of $260.6M and net income of -$81.3M. For detailed data — including TerrAscend Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, TerrAscend Corp. (TRSSF) stock price is $1.72. The stock is traded on OTC under the ticker symbol TRSSF. The 52-week range is $1.00 – $3.09.

TRSSF stock priceTRSSF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice